Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer: Cochrane systematic review

Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer: Cochrane systematic review ID - 435279 BT - Cochrane Abstracts UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435279/all/Poly_ADP_ribose__polymerase__PARP__inhibitors_for_the_treatment_of_ovarian_cancer:_Cochrane_systematic_review DB - Evidence Central DP - Unbound Medicine ER -